Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetazolamide and hydrochlorothiazide followed by furosemide for refractory edema in nephrotic syndrome
IRCT2014081518798N1Phase 3Completed
- Sponsor
- Shiraz Nephrourology Research Center
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of acetazolamide, hydrochlorothiazide and furosemide in nephrosis, sponsored by Shiraz Nephrourology Research Center. Started Aug 2014; status: completed.
02
Drugs
acetazolamidehydrochlorothiazidefurosemide
03
Conditions
nephrosis
Beyond the preview
Go deeper on IRCT2014081518798N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014081518798N1.